{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:25:40Z","timestamp":1774567540895,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930072"],"award-info":[{"award-number":["81930072"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172870"],"award-info":[{"award-number":["82172870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030312003"],"award-info":[{"award-number":["2017A030312003"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013313","name":"Overseas Expertise Introduction Project for Discipline Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["B14035"],"award-info":[{"award-number":["B14035"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2019B020230002"],"award-info":[{"award-number":["2019B020230002"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.radonc.2022.11.005","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T18:30:55Z","timestamp":1668191455000},"page":"205-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study"],"prefix":"10.1016","volume":"177","author":[{"given":"Gaoyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaibin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youyu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linglong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.11.005_b0005","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5732\/cjc.010.10377","article-title":"The prevalence and prevention of nasopharyngeal carcinoma in China","volume":"30","author":"Cao","year":"2011","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.radonc.2022.11.005_b0010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5732\/cjc.010.10547","article-title":"Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy","volume":"30","author":"Su","year":"2011","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.radonc.2022.11.005_b0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2005.12.003","article-title":"Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution","volume":"65","author":"Yi","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.005_b0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijrobp.2007.12.033","article-title":"Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy","volume":"72","author":"Murdoch-Kinch","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.005_b0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.radonc.2007.09.014","article-title":"Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study","volume":"85","author":"Saibishkumar","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.02.017","article-title":"Sparing of the sub- mandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer","volume":"78","author":"Saarilahti","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0035","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/cncr.24049","article-title":"The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma","volume":"115","author":"Tang","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.11.005_b0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2407-12-98","article-title":"Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence","volume":"12","author":"Ho","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2022.11.005_b0045","doi-asserted-by":"crossref","first-page":"579","DOI":"10.5732\/cjc.012.10095","article-title":"Locoregional extension patterns of nasopharyngeal carcinoma and suggestions for clinical target volume delineation","volume":"31","author":"Li","year":"2012","journal-title":"Chin J Cancer"},{"key":"10.1016\/j.radonc.2022.11.005_b0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2012.09.003","article-title":"Proposed lymph node staging system using the international consensus guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy","volume":"86","author":"Li","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.005_b0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.radonc.2015.02.017","article-title":"Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels","volume":"115","author":"Wang","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0060","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.ijrobp.2004.05.022","article-title":"Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience","volume":"60","author":"Kam","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.005_b0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijrobp.2005.03.057","article-title":"Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience","volume":"64","author":"Wolden","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.005_b0070","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","article-title":"Intensity-Modulated Radiation Therapy with or without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0075","doi-asserted-by":"crossref","first-page":"38381","DOI":"10.18632\/oncotarget.5420","article-title":"Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost","volume":"6","author":"Ou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2022.11.005_b0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2009.11.024","article-title":"Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma","volume":"79","author":"Ng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.11.005_b0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1470-2045(11)70303-5","article-title":"Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.anl.2018.10.012","article-title":"Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma","volume":"46","author":"Zeng","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.radonc.2022.11.005_b0095","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3892\/mco.2014.315","article-title":"A risk score model for the metastasis of level Ib lymph node based on the clinicopathological features of nasopharyngeal carcinoma in a large sample","volume":"2","author":"Yi","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2017.10.032","article-title":"International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma","volume":"126","author":"Lee","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0105","article-title":"Prognostic impact of plasma Epstein-Barr Virus DNA in patients with nasopharyngeal carcinoma treated using intensity-modulated radiation therapy","volume":"6","author":"Peng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2022.11.005_b0110","series-title":"Joint Committee on Cancer. AJCC cancer staging manual","author":"American","year":"2017"},{"key":"10.1016\/j.radonc.2022.11.005_b0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/cncr.23555","article-title":"Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging","volume":"113","author":"Tang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.11.005_b0120","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2021.01.015","article-title":"Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: potential improvement for future editions of N category systems","volume":"157","author":"Mao","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0125","doi-asserted-by":"crossref","unstructured":"Gr\u00e9goire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, et al. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol 2014;110:172-81. https:\/\/doi.org\/10.1016\/j.radonc.2013.10.010.","DOI":"10.1016\/j.radonc.2013.10.010"},{"key":"10.1016\/j.radonc.2022.11.005_b0130","doi-asserted-by":"crossref","first-page":"e75304","DOI":"10.1371\/journal.pone.0075304","article-title":"Which T category of nasopharyngeal carcinoma may benefit most from volumetric modulated arc therapy compared with step and shoot intensity modulated radiation therapy","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.radonc.2022.11.005_b0135","series-title":"AJCC cancer staging manual","year":"2010"},{"key":"10.1016\/j.radonc.2022.11.005_b0140","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C, O\u2019Sullivan B, Goldstraw P, Groome P, editors. Union for International Cancer Control (UICC). TNM Classification of Malignant Tumours. 7th ed. Chichester: Wiley-Blackwell; 2010."},{"key":"10.1016\/j.radonc.2022.11.005_b0145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"Sturmer","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2022.11.005_b0150","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s10147-013-0650-6","article-title":"Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma","volume":"19","author":"Chen","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0155","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1259\/bjr.20150621","article-title":"Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study","volume":"89","author":"Li","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2022.11.005_b0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12885-015-1669-z","article-title":"Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2022.11.005_b0165","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13014-017-0869-x","article-title":"The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels","volume":"12","author":"Ou","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0170","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.radonc.2021.12.032","article-title":"Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline","volume":"167","author":"Guo","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0175","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1470-2045(22)00058-4","article-title":"Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial","volume":"23","author":"Tang","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0180","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.radonc.2008.04.008","article-title":"Sparing the contralateral submandibular gland in oropharyngeal cancer patients: a planning study","volume":"89","author":"Houweling","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.11.005_b0185","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ijrobp.2010.07.1990","article-title":"Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study","volume":"81","author":"Wang","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814022045480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:24:13Z","timestamp":1759123453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814022045480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":37,"alternative-id":["S0167814022045480"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}